BioSpace News Archive

Press Releases

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025

February 21, 2025
·
1 min read
Press Releases

Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer

February 21, 2025
·
4 min read
Press Releases

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

February 21, 2025
·
4 min read
Press Releases

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

February 21, 2025
·
4 min read
Press Releases

Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025

February 21, 2025
·
1 min read
Press Releases

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

February 21, 2025
·
1 min read
Press Releases

Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

February 21, 2025
·
26 min read
Press Releases

Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial

February 21, 2025
·
12 min read
Press Releases

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025

February 21, 2025
·
1 min read
Press Releases

ACELYRIN Confirms Receipt of Unsolicited Indication of Interest from Concentra Biosciences

February 21, 2025
·
10 min read